Glycated haemoglobin (HbA1c), a marker of average glycaemia during the previous six to eight weeks, is a predictor of microvascular complications in diabetic individuals. However, the role of HbA1c as a predictor of macrovascular complications (e.g. myocardial infarction or stroke) in these patients is not clearly defined. In contrast, new evidence suggests that HbA1c can predict the risk of ca...

Background: Glycosylated hemoglobin (HbA1c) has been used as an index for clinical diagnosis of diabetes which is closely related to the complications cardiovascular. The purpose study was assess differences in HbA1c against conventional cardiovascular risk obese patients. Method: This cross-sectional conducted on patients (BMI > 25). included 40 patients, whereas those with a history CVD, t...

Total glycosylated haemoglobin (HbA1) levels from capillary blood were studied retrospectively during a 1-year period in 148 diabetic children aged between 1 9 and 16 8 years. The clinic range for HbA1 was 67 to 22 2% and the results were normally distributed (mean ± SD 13 2 ± 28 %). The normal range in non-diabetics using this method is 4 9 to 8-0 %. Results from children who had had diabetes ...

Background: Diabetes mellitus is a chronic metabolic disorder characterized by defect in insulin secretion and action resulting in hyperglycemia. Diabetic patients have deranged body metabolisms particularly for lipids which may result in abnormal levels of serum levels of lipids. Methods: The aim of this study is to find any possible correlation between the the glycosylated hemoglobin and the...